Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease.

This report shows poor adherence to the recommended treatment regimen for NTM-PD patients, which may pose a potential risk for the development of macrolide resistance. The risk was highest among elderly patients, and those with rheumatoid arthritis and COPD. http://bit.ly/3aBoUzE.